Viking Therapeutics Inc — datos financieros trimestrales (NASDAQ:VKTX) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas -31.18 M-52.33 M-47.06 M-94 M-85.29 M -278.69 M Flujo de caja de las actividades de inversión 6.58 M63.24 M42.51 M160.03 M75.61 M 341.39 M Flujo de caja de las actividades financieras 1 M349 K507 K480 K75.1 M 76.44 M Flujo de caja libre -31.18 M-52.33 M-47.06 M-94 M-85.29 M -278.69 M

Noticias

LLY Stock Down as FDA Asks for More Safety Data on Oral Obesity Pill

How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q1 Results?

Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

Viking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth Knowing

NVO Crashes 36% in 3 Months: Is This an Indication to Sell the Stock?

LLY Launches GLP-1 Pill, Expands Access Through Pharmacy Partnerships

3 Best Stocks Under $50 to Buy in April 2026, According to Analysts - TipRanks.com

Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?

WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks

VKTX Finishes Enrollment in Second Late-Stage Study on Obesity Drug